Interpretation of puzzling thyroid function tests
10.5124/jkma.2018.61.4.241
- Author:
Jee Hee YOON
1
;
Ho Cheol KANG
Author Information
1. Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea. drkang@chonnam.ac.kr
- Publication Type:Original Article
- Keywords:
Thyroid function tests;
Diagnostic errors;
Hypothyroidism;
Hyperthyroidism
- MeSH:
Diagnosis;
Diagnosis, Differential;
Diagnostic Errors;
Euthyroid Sick Syndromes;
Homeostasis;
Humans;
Hyperthyroidism;
Hypothyroidism;
Magnetic Resonance Imaging;
Physiology;
Pituitary Neoplasms;
Rare Diseases;
Reference Values;
Sex Hormone-Binding Globulin;
Somatostatin;
Thyroid Diseases;
Thyroid Function Tests;
Thyroid Gland;
Thyrotropin;
Thyrotropin-Releasing Hormone
- From:Journal of the Korean Medical Association
2018;61(4):241-247
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
With the generalized use of highly sensitive thyroid stimulating hormone (TSH) and free thyroid hormone assays, most thyroid function tests (TFTs) are straightforward to interpret and confirm the clinical impressions of thyroid diseases. However, in some patients, TFT results can be perplexing because the clinical picture is not compatible with the tests or because TSH and free T4 are discordant with each other. Optimizing the interpretation of TFTs requires a complete knowledge of thyroid hormone homeostasis, an understanding of the range of tests available to the clinician, and the ability to interpret biochemical abnormalities in the context of the patient's clinical thyroid status. The common etiologic factors causing puzzling TFT results include intercurrent illness (sick euthyroid syndrome), drugs, alteration in normal physiology (pregnancy), hypothalamic-pituitary diseases, rare genetic disorders, and assay interference. Sick euthyroid syndrome is the most common cause of TFT abnormalities encountered in the hospital. In hypothalamic-pituitary diseases, TSH levels are unreliable. Therefore, it is not uncommon to see marginally high TSH levels in central hypothyroidism. Drugs may be the culprit of TFT abnormalities through various mechanisms. Patients with inappropriate TSH levels need a differential diagnosis between TSH-secreting pituitary adenoma and resistance to thyroid hormone. Sellar magnetic resonance imaging, serum α-subunit levels, serum sex hormone-binding globulin levels, a thyrotropin-releasing hormone stimulation test, trial of somatostatin analogues, and TR-β sequencing are helpful for the diagnosis, but it may be challenging. TFTs should be interpreted based on the clinical context of the patient, not just the numbers and reference ranges of the tests, to avoid various pitfalls of TFTs and unnecessary costly evaluations and therapies.
